Capricor Therapeutics
CAPR
#4850
Rank
S$2.37 B
Marketcap
S$41.28
Share price
6.61%
Change (1 day)
217.41%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$1.81 M-98.85%
2025S$0.15 B154.62%
2024S$61.89 M1584.06%
2023S$3.67 M24.67%
2022S$2.94 M-49.93%
2021S$5.88 M-88.57%
2020S$51.49 M573.14%
2019S$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
S$55.5 MS$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$4.15 MS$27.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S$14.08 MS$39.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$1.57 MS$11.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$0.52 MS$1.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/AS$0.06 M๐Ÿ‡บ๐Ÿ‡ธ USA